Literature DB >> 10960918

Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis.

T F Bathen1, J Krane, T Engan, K S Bjerve, D Axelson.   

Abstract

New approaches for quantification of human blood plasma lipids and apolipoproteins are presented. One method is based on multivariate analysis of proton nuclear magnetic resonance spectra of human blood plasma. Although similar approaches have been developed previously, this is the first time principal component analysis (PCA) and partial least squares regression (PLS) have been applied to this particular task. Further, a large proportion of the subjects in this study were cancer patients undergoing treatment, which introduced a new dimension to the quantification of lipoprotein distributions. Calibration models for prediction of lipids and apolipoproteins were constructed by use of PLS, and blind samples were used to test the predictive ability. Comparison of the predicted vs observed data obtained by standard clinical chemical procedures gave good agreement; the correlation coefficient for total plasma triglyceride was 0.99, for total plasma cholesterol 0.98, for LDL cholesterol 0. 97, and for HDL cholesterol 0.88. These results are comparable with those obtained with other methods. The quantitative analysis of 14 components (including total cholesterol and total triglyceride) of human blood plasma was also undertaken using various neural network (NN) analyses of selected portions of the spectra. Conventional fully connected backpropagation neural network topologies were capable of providing excellent predictions for the majority of the variables, confirming and reinforcing literature related to this approach. However HDL triglycerides were poorly predicted, while intermediate-quality results were obtained for the LDL cholesterol, plasma apoA1 and LDL apoB variables. In these instances, applying significantly different neural network algorithms involving either general regression or polynomial neural networks in combination with genetic adaptive components for parameter optimisation made improved predictions. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960918     DOI: 10.1002/1099-1492(200008)13:5<271::aid-nbm646>3.0.co;2-7

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  10 in total

1.  Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Authors:  Ville-Petteri Mäkinen; Pasi Soininen; Carol Forsblom; Maija Parkkonen; Petri Ingman; Kimmo Kaski; Per-Henrik Groop; Mika Ala-Korpela
Journal:  MAGMA       Date:  2006-12-15       Impact factor: 2.310

2.  1H NMR spectroscopy quantifies visibility of lipoproteins, subclasses, and lipids at varied temperatures and pressures.

Authors:  Daniela Baumstark; Werner Kremer; Alfred Boettcher; Christina Schreier; Paul Sander; Gerd Schmitz; Renate Kirchhoefer; Fritz Huber; Hans Robert Kalbitzer
Journal:  J Lipid Res       Date:  2019-06-25       Impact factor: 5.922

3.  Hyphenated tools for phospholipidomics.

Authors:  Jan Willmann; Dieter Leibfritz; Herbert Thiele
Journal:  J Biomol Tech       Date:  2008-07

4.  Discovery of metabolite features for the modelling and analysis of high-resolution NMR spectra.

Authors:  Hyun-Woo Cho; Seoung Bum Kim; Myong K Jeong; Youngja Park; Nana Gletsu Miller; Thomas R Ziegler; Dean P Jones
Journal:  Int J Data Min Bioinform       Date:  2008       Impact factor: 0.667

5.  A sulfur amino acid-free meal increases plasma lipids in humans.

Authors:  Youngja Park; Ngoc-Anh Le; Tianwei Yu; Fred Strobel; Nana Gletsu-Miller; Carolyn J Accardi; Kichun S Lee; Shaoxiong Wu; Thomas R Ziegler; Dean P Jones
Journal:  J Nutr       Date:  2011-06-15       Impact factor: 4.798

6.  Combined reversed phase HPLC, mass spectrometry, and NMR spectroscopy for a fast separation and efficient identification of phosphatidylcholines.

Authors:  Jan Willmann; Herbert Thiele; Dieter Leibfritz
Journal:  J Biomed Biotechnol       Date:  2010-08-25

7.  Metabolomic biomarkers in serum and urine in women with preeclampsia.

Authors:  Marie Austdal; Ragnhild Bergene Skråstad; Astrid Solberg Gundersen; Rigmor Austgulen; Ann-Charlotte Iversen; Tone Frost Bathen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

8.  Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer.

Authors:  Mohamad Nasir Shafiee; Catharine A Ortori; David A Barrett; Nigel P Mongan; Jafaru Abu; William Atiomo
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

9.  The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B.

Authors:  Erwin Garcia; Dennis W Bennett; Margery A Connelly; Elias J Jeyarajah; Franklin C Warf; Irina Shalaurova; Steven P Matyus; Justyna Wolak-Dinsmore; David N Oskardmay; Randolph M Young; Maureen Sampson; Alan T Remaley; James D Otvos
Journal:  Lipids Health Dis       Date:  2020-12-01       Impact factor: 3.876

10.  A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data.

Authors:  Aki Vehtari; Ville-Petteri Mäkinen; Pasi Soininen; Petri Ingman; Sanna M Mäkelä; Markku J Savolainen; Minna L Hannuksela; Kimmo Kaski; Mika Ala-Korpela
Journal:  BMC Bioinformatics       Date:  2007-05-03       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.